Some weight loss medications might make these issues worse
Whether your focus is blood sugar management, weight loss, or metabolic wellness, were here to help you navigate your journey safely and effectively.
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Report any sudden mood worsening, suicidal thoughts, or emotional instability to your PlexusDx provider immediately, as these may warrant dose adjustment or alternative treatment consideration
Exendin-4 significantly increased insulin level and phosphorylation of insulin receptor substrate 1 (IRS-1) in rat hippocampus, and could not change the status of tau phosphorylation without insulin in HT22 neurons, suggesting that insulin is required in reduction of tau hyperphosphorylation by GLP-1R agonists (154)
Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
